Karen Hoffman, MD, FASTRO

MD Anderson Cancer Center
Houston, Texas

Disclosures:

• Employment: MD Anderson Cancer Center:Professor:Employee
• Compensation: Janssen: Research Grants, Research Funding, Research Salary Support, Grant Research Funding-End Date: present ;Varian Medial Systems: Research Grants, Research Funding, Research Salary Support, Grant Research Funding-End Date: 2024
• Ownership: none
• Leadership: ASTRO:ASTRO representative to the Commission on Cancer

Presentation(s):

• 100 - Primary Outcome Analysis for Shortening Adjuvant Photon Irradiation to Reduce Edema (SAPHIRE): A Randomized, Phase III Trial of Hypo- vs. Conventionally Fractionated Regional Nodal Irradiation (RNI)

  Sunday, September 29, 2024
  8:00 AM – 8:10 AM ET

• 181 - Long-Term Patient-Reported Health-Related Quality of Life in the Randomized FORMULA-509 Trial of Salvage Radiotherapy and 6 Months of GnRH Agonist with Either Bicalutamide or Abiraterone Acetate Plus

  Monday, September 30, 2024
  10:45 AM – 10:55 AM ET